RAPGEF3 and diabetes mellitus: Interestingly, at 6 months of diabetes, Epac1 and glycyrrhizin displayed the trend to work synergistically to reduce ROS, as the levels in Epac1 floxed + STZ + glycyrrhizin were reduced more than Epac1 CreLox + STZ + glycyrrhizin.